These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1354036)

  • 21. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine.
    Kraus T; Schuld A; Pollmächer T
    J Clin Psychopharmacol; 1999 Oct; 19(5):478-9. PubMed ID: 10505594
    [No Abstract]   [Full Text] [Related]  

  • 22. Lurasidone suppresses rapid eye movement sleep and improves sleep quality in rats.
    Murai T; Nakamichi K; Shimizu I; Ikeda K
    J Pharmacol Sci; 2014; 126(2):164-7. PubMed ID: 25231559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic disturbances associated with antipsychotic use.
    Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():3-4; discussion 40-1. PubMed ID: 11806487
    [No Abstract]   [Full Text] [Related]  

  • 24. Clozapine-induced cataplexy.
    Desarkar P; Goyal N; Khess CR
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):87-8. PubMed ID: 17308237
    [No Abstract]   [Full Text] [Related]  

  • 25. New findings on antipsychotic use in children and adolescents with schizophrenia spectrum disorders.
    Ross RG
    Am J Psychiatry; 2008 Nov; 165(11):1369-72. PubMed ID: 18981065
    [No Abstract]   [Full Text] [Related]  

  • 26. The psychophysiology of sleep in psychotic depression: a longitudinal study.
    Hawkins DR; Mendels J; Scott J; Bensch G; Teachey W
    Psychosom Med; 1967; 29(4):329-44. PubMed ID: 6059910
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neurological experiences with the new hypnotic dormopan].
    HAU EC
    Med Klin; 1959 Apr; 54(16):785. PubMed ID: 13656365
    [No Abstract]   [Full Text] [Related]  

  • 28. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
    Bradford DW; Perkins DO; Lieberman JA
    Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Nykänen S; Puska V; Tolonen JP; Salo H; Isohanni M; Koponen H; Pirkola S; Penttilä M; Haapea M; Moilanen J; Miettunen J; Jääskeläinen E
    Psychiatry Res; 2016 Jan; 235():160-8. PubMed ID: 26652841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.
    Monti JM; Torterolo P; Pandi Perumal SR
    Sleep Med Rev; 2017 Jun; 33():51-57. PubMed ID: 27321864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Health Checks in Patients on Antipsychotic Medication.
    Lau G; Murphy J; Chaudhury N; Agius M
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):608-612. PubMed ID: 31488799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review.
    Christodoulou C; Kalaitzi C
    J Psychopharmacol; 2005 May; 19(3):307-11. PubMed ID: 15888517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug treatment of functional psychotic disorders].
    Bridler R; Umbricht D; Hell D
    Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect: effective and free of side effects].
    Fortschr Neurol Psychiatr; 1998 Oct; 66(10 Suppl Schizophre):1-4. PubMed ID: 9828949
    [No Abstract]   [Full Text] [Related]  

  • 37. The response of psychotic symptoms in a patient with resistant schizophrenia under treatment of high-dose risperidone long-acting injection.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E16-7. PubMed ID: 25093771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].
    Slooff CJ; Arends J
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):400-1; author reply 401. PubMed ID: 16523806
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
    Buckley PF
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
    [No Abstract]   [Full Text] [Related]  

  • 40. The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosis.
    Tamminga CA; Carpenter WT
    J Nerv Ment Dis; 1982 Dec; 170(12):744-51. PubMed ID: 6128375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.